George B. Thornton
9Patents
5h-index
5Co-inventors
52Inventor score
Filing activity: Dec 9, 1986 → Jul 24, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5143726A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 52 | Expired |
| US4818527A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 52 | Expired |
| US4882145A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5599790A | Fibrinogen .gamma. chain polypeptide and compositions thereof | Chemistry; Metallurgy | 15 | Expired |
| US4908203A | Method for inducing HIV neutralizing antibodies using an internal image idiotope | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5919754A | Method of inhibiting fibrinogen binding to endothelial cells with fibrinogen gamma chain peptides | Chemistry; Metallurgy | 5 | Expired |
| US6737058B2 | Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodies | Chemistry; Metallurgy | 4 | Expired |
| US6265549A | Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation | Chemistry; Metallurgy | 2 | Expired |
| US6676940B2 | Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.